financetom
Business
financetom
/
Business
/
What's Going On With Boeing Shares Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Boeing Shares Tuesday?
Sep 11, 2024 3:47 AM

Boeing Company ( BA ) shares are trading lower on Tuesday. The company reportedly informed suppliers of a six-month delay in a key production milestone for its 737 MAX.

Also, today, the company disclosed the planned launch of its Q4S satellite in 2026.

This Boeing ( BA )-funded mission marks a significant step toward developing a secure global quantum internet connecting quantum sensors and computers.

This experiment aims to demonstrate quantum networking in space, advancing the understanding of how such networks can be built across vast distances while maintaining precise synchronization.

Also See: Boeing’s Tentative Union Deal And Starliner Return Boost Sentiment, But Analyst Remains Neutral Pending Vote

Jay Lowell, chief engineer for Boeing’s Disruptive Computing, Networks & Sensors organization, said, “Quantum entanglement swapping underpins the communication of the future, expanding quantum networks beyond simple point-to-point communication. We’re launching Q4S to prove it can be done in orbit.”

“By demonstrating entanglement swapping, we can create a scalable network, where quantum information can be transmitted over vast distances, something currently limited by decoherence and loss,” 

Apart from this, Boeing ( BA ) stated that it delivered 40 commercial jets in August, five more than in the same month of 2023 when a manufacturing defect affected 737 MAX production, reported Reuters.

Last week, Boeing’s troubled space capsule, Starliner, returned to Earth without any crew after a test flight fraught with technical issues and delays.

The mission has garnered global attention due to numerous technical problems that led NASA to extend the stays of astronauts Barry Wilmore and Sunita Williams.

Investors can gain exposure to the stock via IShares U.S. Aerospace & Defense ETF ( ITA ) and Gabelli Commercial Aerospace and Defense ETF ( GCAD ) .

Price Action: BA shares are down 2.82% at $158.32 at the last check Tuesday.

Read Next:

Boeing Labor Deal Sparks Anger Among Union Workers Ahead Of Crucial Vote: ‘They’re Angry’

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BYD to nail down Mexico plant site by year-end, Americas head says
BYD to nail down Mexico plant site by year-end, Americas head says
May 14, 2024
MEXICO CITY (Reuters) - Chinese electric auto maker BYD expects to have chosen a site to build a plant in Mexico, where it will put out up to 150,000 cars a year, by the end of 2024, the firm's Americas head said on Tuesday. The plant will be built in central Mexico, Americas head Stella Li told Reuters in an...
Ferrari Prices Notes Offering Due May 2030
Ferrari Prices Notes Offering Due May 2030
May 14, 2024
02:39 PM EDT, 05/14/2024 (MT Newswires) -- Ferrari ( RACE ) said Tuesday it has priced its offering of 500 million euros ($541.1 million) of notes due in May 2030 at 99.677% of the principal amount. The company said the notes have a fixed annual coupon of 3.625%. Ferrari ( RACE ) said it will use the proceeds for general...
JPMorgan pushes back on ISS recommendations on severance, independent chair
JPMorgan pushes back on ISS recommendations on severance, independent chair
May 14, 2024
(Reuters) -JPMorgan Chase on Monday pushed back against recommendations made by proxy advisor Institutional Shareholder Services (ISS) on investor proposals on severance payouts and the separation of the CEO and board chair positions. ISS had supported the proposal that two separate people hold the office of the chairman and the office of the CEO, both roles currently held by Jamie...
FDA extends review of Ascendis Pharma's hormone disorder therapy
FDA extends review of Ascendis Pharma's hormone disorder therapy
May 14, 2024
May 14 (Reuters) - The U.S. Food & Drug Administration has extended its review of Ascendis Pharma's ( ASND ) therapy to treat adult patients with a hormone disorder, the company said on Tuesday. The FDA is now set to make its decision known by Aug. 14, compared to its previous action date set for May 14. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved